The companies entered into a definitive agreement for the $4.9 billion acquisition in January. The deal will support Stryker’s neurovascular business.
Inari was founded in 2011 and makes products for VTE clot removal without thrombolytic drugs.
Stryker completes Inari Medical acquisition
Stryker completed its acquisition of Inari Medical, the devicemaker said Feb. 19.
Reducing the need for contingent labor by leveraging technology: Geisinger’s playbook for transforming the workforce
Recommended Live Webinar on Apr 23, 2025 12:00 PM - 1:00 PM CDT